Product
TS-1
3 clinical trials
4 indications
Indication
Stomach CancerIndication
Pancreatic Cancer Stage IIIIndication
Pancreatic CancerIndication
Biliary Tract CancerClinical trial
A Phase IIb, Clinical Trial to Study the Safety and Efficacy of Pembrolizumab (MK-3475) in Combination With TS-1+Cisplatin or TS-1+Oxaliplatin as a First Line Chemotherapy in Participants With Advanced or Recurrent Gastric Cancer (KEYNOTE-659)Status: Completed, Estimated PCD: 2021-05-30
Clinical trial
Phase I Study of Combination With TBI-1401(HF10), a Replication-competent HSV-1 Oncolytic Virus, and Chemotherapy in Patients With Stage III or IV Unresectable Pancreatic Cancer.Status: Active (not recruiting), Estimated PCD: 2020-02-19
Clinical trial
A Study of Nivolumab Combination Gemcitabine and S1 as the First-Line Treatment in Patients With Advanced Biliary Tract CancerStatus: Active (not recruiting), Estimated PCD: 2024-12-31